R97.20, Elevated prostate specific antigen [PSA]ICD-10-CM
No Prior Auth Required
Covered without prior authorization (high confidence)
CGS-J15-L39284, Prostate Cancer Detection with IsoPSA®
J15
CGS-J15-L38997, MolDX: Molecular Biomarkers to Risk-Stratify Patients at Increased Risk for Prostate Cancer
J15
CGS-J18-L38997, MolDX: Molecular Biomarkers to Risk-Stratify Patients at Increased Risk for Prostate Cancer
J18
CGS-J18-L39284, Prostate Cancer Detection with IsoPSA®
J18
Ask Backwork about documentation requirements, denial risks, or coverage in your state.
WPS-J5-L39042, MolDX: Molecular Biomarkers to Risk-Stratify Patients at Increased Risk for Prostate Cancer
J5
A58759, Billing and Coding: MolDX: Molecular Biomarkers to Risk-Stratify Patients at Increased Risk for Prostate Cancer
J5
NGS-J6-L33578, Transrectal Ultrasound
J6
A57427, Billing and Coding: Transrectal Ultrasound
J6
WPS-J8-L39042, MolDX: Molecular Biomarkers to Risk-Stratify Patients at Increased Risk for Prostate Cancer
J8
FIRST_COAST-L37798, 4Kscore Test Algorithm
J9
A56287, Billing and Coding: 4Kscore Test Algorithm
J9
NOVITAS-JH-L37792, 4Kscore Test Algorithm
JH
NGS-JK-L33578, Transrectal Ultrasound
JK
NOVITAS-JL-L37792, 4Kscore Test Algorithm
JL
A56653, Billing and Coding: 4Kscore Test Algorithm
JL
A59066, Billing and Coding: Prostate Cancer Detection with IsoPSA
AETNA-CPB-0071, Positron Emission Tomography (PET)
ANTHEM-CG-RAD-28, Transrectal Ultrasonography
A58700, Billing and Coding: MolDX: Molecular Biomarkers to Risk-Stratify Patients at Increased Risk for Prostate Cancer
A58713, Billing and Coding: MolDX: Molecular Biomarkers to Risk-Stratify Patients at Increased Risk for Prostate Cancer